NOD2 is dispensable for ATG16L1 deficiency-mediated resistance to urinary tract infection

NOD2 (nucleotide-binding oligomerization domain containing 2) functions as a pathogen sensor and is involved in development of Crohn disease, a form of inflammatory bowel disease. NOD2 functions in concert with the autophagy protein ATG16L1, which is also implicated in Crohn disease. Recently, we identified a novel protective role of ATG16L1 deficiency in uropathogenic Escherichia coli-induced urinary tract infections (UTIs), which are common infectious diseases in humans. Given the known roles of NOD2 in recruiting ATG16L1 to the bacterial entry site, autophagy induction, and Crohn disease, we hypothesized that NOD2 may also play an important role in UTI pathogenesis. Instead, we found evidence that NOD2 is dispensable in the pathogenesis of UTIs in mice and humans. First, loss of Nod2 did not affect the clearance of bacteriuria and the recruitment of innate immune cells to the bladder. Second, we showed that, although nod2−/− mice display increased kidney abscesses in the upper urinary tract, there were no increased bacterial loads or persistence in this niche. Third, although a previous study indicates that loss of Nod2 reverses the protection from intestinal infection afforded by loss of ATG16L1 in mice, we found NOD2 deficiency did not reverse the ATG16L1-deficiency-induced protection from UTI. Finally, a population-based study of a cohort of 1819 patients did not reveal any association of NOD2 polymorphisms with UTI incidence. Together, our data indicated that NOD2 is dispensable for UTI pathogenesis in both mice and humans and does not contribute to ATG16L1-deficiency-induced resistance to UTI in mice.

[1]  W. Strober,et al.  Nod2 deficiency is associated with an increased mucosal immunoregulatory response to commensal microorganisms , 2013, Mucosal Immunology.

[2]  Vanessa M. Hubbard-Lucey,et al.  A deficiency in the autophagy gene Atg16L1 enhances resistance to enteric bacterial infection. , 2013, Cell host & microbe.

[3]  Paul G. Thomas,et al.  Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infection , 2013, Nature Immunology.

[4]  I. Mysorekar,et al.  ATG16L1 and pathogenesis of urinary tract infections , 2012, Autophagy.

[5]  Yu-jin Jeong,et al.  Nucleotide-binding oligomerization domain 2 (Nod2) is dispensable for the innate immune responses of macrophages against Yersinia enterocolitica , 2012, Journal of Microbiology.

[6]  Qunyuan Zhang,et al.  Atg16L1 deficiency confers protection from uropathogenic Escherichia coli infection in vivo , 2012, Proceedings of the National Academy of Sciences.

[7]  M. Bringer,et al.  Defects in autophagy favour adherent‐invasive Escherichia coli persistence within macrophages leading to increased pro‐inflammatory response , 2012, Cellular microbiology.

[8]  J. Hugot,et al.  Yersinia pseudotuberculosis effector YopJ subverts the Nod2/RICK/TAK1 pathway and activates caspase-1 to induce intestinal barrier dysfunction. , 2012, Cell host & microbe.

[9]  Fernanda S. Oliveira,et al.  Nucleotide-Binding Oligomerization Domain-1 and -2 Play No Role in Controlling Brucella abortus Infection in Mice , 2011, Clinical & developmental immunology.

[10]  L. Joosten,et al.  ATG16L1 polymorphisms are associated with NOD2-induced hyperinflammation , 2011, Autophagy.

[11]  N. Warner,et al.  The Nod2 sensor promotes intestinal pathogen eradication via the chemokine CCL2-dependent recruitment of inflammatory monocytes. , 2011, Immunity.

[12]  M. Oosting,et al.  Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2 , 2011, Gut.

[13]  Tariq Ahmad,et al.  Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci , 2010, Nature Genetics.

[14]  C. Streutker,et al.  Nod1 and Nod2 Regulation of Inflammation in the Salmonella Colitis Model , 2010, Infection and Immunity.

[15]  A. Darfeuille‐Michaud,et al.  Abnormalities in the Handling of Intracellular Bacteria in Crohn's Disease , 2010, Journal of clinical gastroenterology.

[16]  R. Xavier,et al.  Crohn's disease‐associated adherent‐invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly , 2010, Cellular microbiology.

[17]  D. Philpott,et al.  Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry , 2010, Nature Immunology.

[18]  D. Jewell,et al.  NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation , 2010, Nature Medicine.

[19]  D. Philpott,et al.  Role of Nod1 in Mucosal Dendritic Cells during Salmonella Pathogenicity Island 1-Independent Salmonella enterica Serovar Typhimurium Infection , 2009, Infection and Immunity.

[20]  S. Hultgren,et al.  A murine model of urinary tract infection , 2009, Nature Protocols.

[21]  J. Mills,et al.  Bone morphogenetic protein 4 signaling regulates epithelial renewal in the urinary tract in response to uropathogenic infection. , 2009, Cell host & microbe.

[22]  Sarah L. Brown,et al.  A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells , 2008, Nature.

[23]  Tony Fletcher,et al.  Sequence variant on 8q24 confers susceptibility to urinary bladder cancer , 2008, Nature Genetics.

[24]  M. Daly,et al.  Impaired Autophagy of an Intracellular Pathogen Induced by a Crohn's Disease Associated ATG16L1 Variant , 2008, PloS one.

[25]  J. Hugot,et al.  Nod2 Mediates Susceptibility to Yersinia pseudotuberculosis in Mice , 2008, PloS one.

[26]  P. Humphrey,et al.  Detection of Intracellular Bacterial Communities in Human Urinary Tract Infection , 2007, PLoS medicine.

[27]  R. Xavier,et al.  Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.

[28]  S. Fisher,et al.  A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5. , 2007, Gastroenterology.

[29]  Judy H Cho,et al.  Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis , 2007, Nature Genetics.

[30]  G. Núñez,et al.  RICK/RIP2 Mediates Innate Immune Responses Induced through Nod1 and Nod2 but Not TLRs1 , 2007, The Journal of Immunology.

[31]  D. Philpott,et al.  Nod-like proteins in immunity, inflammation and disease , 2006, Nature Immunology.

[32]  S. Hultgren,et al.  Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract , 2006, Proceedings of the National Academy of Sciences.

[33]  Richard A. Flavell,et al.  Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract , 2005, Science.

[34]  Michael Karin,et al.  Nod2 Mutation in Crohn's Disease Potentiates NF-κB Activity and IL-1ß Processing , 2005, Science.

[35]  S. Hultgren,et al.  Intracellular Bacterial Biofilm-Like Pods in Urinary Tract Infections , 2003, Science.

[36]  Y. Ogura,et al.  Genetic variation and activity of mouse Nod2, a susceptibility gene for Crohn's disease. , 2003, Genomics.

[37]  M. Chamaillard,et al.  Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection* , 2003, The Journal of Biological Chemistry.

[38]  S. Foster,et al.  Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2 , 2003, The Journal of Biological Chemistry.

[39]  Judy H. Cho,et al.  Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. , 2003, Gastroenterology.

[40]  Judy H. Cho,et al.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.

[41]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.